It is well known that foaming can become a major problem during large-scale recombinant protein bioprocesses; the vigorous stirring and introduction of gases to maintain the required dissolved oxygen (DO) concentration for the organism [1] in addition to the growth medium and protein products themselves [2], can result in the formation and stabilization of foams consisting of gas-filled liquid lamellas. Both unstable high liquid content foams and stable dry polyhedric foams may be present in a bioprocess [3] and readily accumulate. Unchecked build up of foams may result in foam escaping from the vessel, loss of sterility [4] and material, while bursting bubbles may damage proteins and cells [5] in addition to the blockage of exit filters which can pressurize the vessel and damage equipment.A common method of foam destruction is the addition of chemical antifoaming agents. Many types of antifoams are commercially available with a range of properties and varied foam destruction efficiency, with some becoming depleted requiring several additions over time [6]. They may contain surfactants and can consist of hydrophobic solids dispersed in carrier oil, aqueous suspensions or emulsions, liquid single components or solids [7]. Some examples of antifoams of a range of types are; Antifoams A and C (Sigma) which are both 30% emulsions of silicone polymer, J673A (Struktol) an alkoxylated fatty acid ester on a vegetable base, P2000 (Fluka) which is a polypropylene glycol, PEG600 and PEG8000 (Sigma) which are both polyethylene glycols, S184 (Wacker-Chemie Co.) which is a silicone oil, SB2121 (Struktol) a polyalkylene glycol, SE9 (Wacker-Chemie Co.) an emulsion containing 10% S184, and SLM54474 (Wacker-Chemie Co.) a polypropylene glycol. Most investigations concerning antifoams evaluate their defoaming capabilities; foam formation has been thoroughly characterized, and the main mechanisms of foam destruction have been explained, although some details of their action are not completely understood. This is partly due to submicroscopic events occurring during foam destruction and the complex involvement of the numerous active components of the agents [6], about which little information is generally provided by the manufacturer. Methods such as the Bartsch shaking test [8] and Ross-Miles pouring test [9] allow simple evaluation of antifoam efficiency and mathematical models have been generated allowing optimization of their addition to bioprocesses [6].Unexpectedly, considering their frequent use as an additive, there is significantly less information available concerning the biological effects of antifoaming agents and very little of this is recent. Present research has found that antifoams can have a broad range of effects upon bioprocesses, both on the culture environment and upon the cells themselves. The effects of these agents therefore warrant a more detailed evaluation. However, while many studies producing recombinant protein by large scale fermentation report the addition of antifoams, usually only the volume or concen...